Cargando…
Do Patients’ and Physicians’ Perspectives Differ on Preferences for Irritable Bowel Syndrome Treatment?
Irritable bowel syndrome (IBS) is a highly prevalent disorder of gut–brain interaction and poses a significant burden to patients. Pharmacotherapy, diet, and psychotherapy all have largely comparable clinical efficacy. Therefore, factors outside efficacy can have an important impact in determining p...
Autores principales: | Sturkenboom, Rosel, Essers, Brigitte A B, Masclee, Ad A M, Keszthelyi, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806363/ https://www.ncbi.nlm.nih.gov/pubmed/36601326 http://dx.doi.org/10.1177/23743735221147762 |
Ejemplares similares
-
The estimation of a preference-based single index for the IBS-QoL by mapping to the EQ-5D-5L in patients with irritable bowel syndrome
por: Sturkenboom, Rosel, et al.
Publicado: (2021) -
Patient preferences of healthcare delivery in irritable bowel syndrome: a focus group study
por: Masclee, Gwen M. C., et al.
Publicado: (2021) -
Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study
por: Keszthelyi, Daniel, et al.
Publicado: (2012) -
A trial‐based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome
por: Weerts, Zsa Zsa R. M., et al.
Publicado: (2021) -
Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational Study
por: Weerts, Zsa Zsa R M, et al.
Publicado: (2020)